| Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia (NCT01286038) | H. Lee Moffitt Cancer Center and Research Institute | 2011-04-06 |
| A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) (NCT00961064) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-03-15 |
| Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP (NCT01805648) | Peking Union Medical College | 2011-02-01 |
| The International ITP Registry (NCT01970189) | South Eastern Sydney Local Health District | 2011-01-01 |
| Pathogen Reduction Evaluation & Predictive Analytical Rating Score (NCT02783313) | Sanquin Research & Blood Bank Divisions | 2010-11-17 |
| Effect of Hemodialysis Membranes on Platelet Count (NCT01356576) | Northwell Health | 2010-09-01 |
| Immune Thrombocytopenia (ITP) Immune-Genetic Assessment (NCT01196884) | Azienda Sanitaria-Universitaria Integrata di Udine | 2010-09-01 |
| Study of Eltrombopag in Platelet Refractory Thrombocytopenia (NCT01194167) | University of Cincinnati | 2010-08-01 |
| Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia (NCT01153919) | University of Southern California | 2010-06-30 |
| Eltrombopag for Post Transplant Thrombocytopenia (NCT01000051) | M.D. Anderson Cancer Center | 2010-02-17 |
| Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP) (NCT01162941) | Cooperative Study Group A for Hematology | 2010-02-01 |
| Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01002755) | M.D. Anderson Cancer Center | 2010-01-19 |
| Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation (NCT00903929) | Jane Liesveld | 2009-12-01 |
| Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) (NCT00907478) | Amgen | 2009-08-11 |
| Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients (NCT00909363) | Weill Medical College of Cornell University | 2009-06-01 |
| A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients (NCT00922883) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-05-29 |
| The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC (NCT02344979) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2009-05-01 |
| Study of the Effect of Differing Platelet Transfusion Times in Neonates (NCT00948792) | University of Oklahoma | 2009-05-01 |
| Transfusing Neonates Based on Platelet Mass (NCT00759980) | Christiana Care Health Services | 2008-10-01 |
| Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer (NCT00771810) | Tarix Pharmaceuticals | 2008-10-01 |
| Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells (NCT00730314) | Children's Hospital Los Angeles | 2008-08-01 |
| Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00735930) | National Cancer Institute (NCI) | 2008-08-01 |
| Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) (NCT00614523) | Amgen | 2008-07-21 |
| Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation) (NCT00748878) | University of Utah | 2008-06-01 |
| Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures (NCT00678587) | GlaxoSmithKline | 2008-06-01 |
| Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) (NCT00594685) | Carelon Research | 2008-01-01 |
| Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) (NCT00472290) | Amgen | 2007-04-01 |
| Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) (NCT00413283) | Amgen | 2006-12-01 |
| Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura (NCT00415532) | Amgen | 2006-12-01 |
| A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid (NCT00418665) | Amgen | 2006-12-01 |
| Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy (NCT00471653) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2006-11-11 |
| Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents (NCT00321711) | Amgen | 2006-10-01 |
| Mechanism of Thrombocytopenia in Infants (NCT00333333) | Christiana Care Health Services | 2006-06-01 |
| Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) (NCT00454857) | Amgen | 2006-05-01 |
| Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) (NCT00303472) | Amgen | 2006-02-01 |
| Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products (NCT00263809) | Terumo BCTbio | 2005-12-01 |
| Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia (NCT00260689) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-11-28 |
| Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days (NCT00261924) | Cerus Corporation | 2005-10-01 |
| A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma (NCT00283439) | Amgen | 2005-10-01 |
| Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children (NCT00118664) | Children's Healthcare of Atlanta | 2005-05-01 |
| AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy (NCT00102336) | Amgen | 2005-04-07 |
| SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C (NCT00110799) | GlaxoSmithKline | 2005-04-01 |
| AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy (NCT00102323) | Amgen | 2005-03-29 |
| Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection (NCT00239733) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-01 |
| An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP (NCT00508820) | Amgen | 2005-02-01 |
| Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B Cirrhosis (NCT01987791) | Peking University People's Hospital | 2005-01-01 |
| Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) (NCT00116688) | Amgen | 2004-08-01 |
| Optimal Platelet Dose Strategy for Management of Thrombocytopenia (NCT00128713) | Carelon Research | 2004-07-01 |
| Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy (NCT01163110) | Midwestern Regional Medical Center | 2004-03-01 |
| Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) (NCT00073580) | The Medicines Company | 2003-10-01 |
| Strategies for Transfusion of Platelets (SToP) (NCT00420914) | Hamilton Health Sciences Corporation | 2003-10-01 |
| Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma (NCT00151866) | Sanquin Research & Blood Bank Divisions | 2003-10-01 |
| Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (NCT00039858) | Encysive Pharmaceuticals | 2003-09-01 |
| Thrombopoietin Levels and Platelet Transfusion in Neonates (NCT00549484) | Christiana Care Health Services | 2003-05-01 |
| Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen (NCT00074165) | OHSU Knight Cancer Institute | 2003-01-01 |
| Daclizumab to Treat Chronic Immune Thrombocytopenia (NCT00049725) | National Institutes of Health Clinical Center (CC) | 2002-11-01 |
| Platelet Count Trends in Pre-eclamptic Parturients (NCT00787241) | Northwestern University | 2002-09-01 |
| Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer (NCT00031980) | Alliance for Clinical Trials in Oncology | 2002-03-01 |
| Aspirin in Patients With Myocardial Infarction and Thrombocytopenia (NCT00501345) | M.D. Anderson Cancer Center | 2002-02-01 |
| Blood Products in Cardiac Surgery (NCT02068755) | University of Turku | 2002-01-01 |
| Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment (NCT00608738) | Northwestern University | 2001-07-01 |
| Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission (NCT00305708) | University of California, San Francisco | 2000-08-01 |
| Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia (NCT00039910) | Pfizer | 2000-07-01 |
| Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia (NCT00037791) | Pfizer | 1999-12-01 |
| Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia (NCT00004215) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia (NCT00003619) | Drexel University College of Medicine | 1998-02-01 |
| Treatment of Autoimmune Thrombocytopenia (AITP) (NCT00001630) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-07-21 |
| Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine (NCT00001533) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia (NCT00002665) | SWOG Cancer Research Network | 1995-07-01 |
| Stem Cell Transplantation (SCT) for Genetic Diseases (NCT00004378) | National Center for Research Resources (NCRR) | 1995-01-01 |
| Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes (NCT00004787) | National Center for Research Resources (NCRR) | 1994-12-01 |
| Managed Access Programs for ETB115, Eltrombopag (NCT04837703) | Novartis Pharmaceuticals | |